Russell Investments Group
JUNS

Russell Investments Group’s Jupiter Neurosciences JUNS Stock Holding History

Russell Investments Group’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40
Closed -$3.06K – 4340
2025
Q4 		$3.06K Buy
+40
New +$3.99K ﹤0.01% 3965

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59B AUM 51.04% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.41B AUM

Russell Investments Group's JUNS Position: Q1 2026 in Review

Russell Investments Group sold out of Jupiter Neurosciences (JUNS) in Q1 2026, closing a stake of 40 shares — an estimated $3.06K sold.

Russell Investments Group first reported a position in JUNS in Q4 2025 and held it in 1 quarter. The position peaked at $3.06K in Q4 2025. 10 funds tracked by Wall St. Rank hold JUNS as of Q1 2026.

  • Russell Investments Group reported no remaining Jupiter Neurosciences position as of Q1 2026 after selling out during the quarter.
  • Russell Investments Group sold 40 Jupiter Neurosciences shares in Q1 2026, an estimated $3.06K.
  • Russell Investments Group first reported a position in Jupiter Neurosciences in Q4 2025 and held it in 1 quarter.
  • Russell Investments Group's Jupiter Neurosciences position peaked at $3.06K in Q4 2025.
  • 10 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.